Irvin M. Modlin

28.2k citations

393 papers · 20.6k indexed · 8 hit papers · h-index 71

Impact in

Neurology top 0.05%
- Neuroblastoma Research and Treatments
Gastroenterology top 0.1%
- Gastrointestinal Tumor Research and Treatment

Papers in

Gastroenterology 45
- Gastroesophageal reflux and treatments 26
Neurology 99
- Neuroblastoma Research and Treatments 94

Co-authors: Mark Kidd Kevin D. Lye András Sándor Björn Gustafsson Ignat Drozdov Lisa Bodei Anthony Chan Michael D. Shapiro
Journals: Journal of Clinical Gastroenterology (22 papers)Journal of Surgical Research (21 papers)Gastroenterology (20 papers)American Journal of Physiology-Gastrointestinal and Liver Physiology (17 papers)Neuroendocrinology (16 papers)
Partner nations: United States Germany United Kingdom

In The Last Decade

Irvin M. Modlin

385 papers receiving 19.8k citations

Hit Papers

8 papers align trajectories log scale

Recommendations for management of patients with neuroendocrine liver metastases 2014 · 349 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2014 The Lancet Oncology
2014 European Journal of Nuclear Medicine and Molecular Imaging
2011 Endocrinology and Metabolism Clinics of North America
2008 The Lancet Oncology
2005 Gastroenterology
2003 Cancer
2000 Cancer
1997 The American Journal of Surgery

Peers

Countries citing papers authored by Irvin M. Modlin

Since Specialization

Citations

This map shows the geographic impact of Irvin M. Modlin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Irvin M. Modlin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Irvin M. Modlin more than expected).

Fields of papers citing papers by Irvin M. Modlin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Irvin M. Modlin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Irvin M. Modlin. The network helps show where Irvin M. Modlin may publish in the future.

Co-authors

The 25 scholars most cited alongside Irvin M. Modlin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Irvin M. Modlin Line = papers co-authored together Irvin M. Modlin links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Development of a multigenomic liquid biopsy (PROSTest) for prostate cancer in whole blood The Prostate ·Irvin M. Modlin, Mark Kidd, Ignat Drozdov, Martin Boegemann, Lisa Bodei, Jolanta Kunikowska, Anna Malczewska, Christof Bernemann, Srinivas V. Koduru, Kambiz Rahbar	2024	10
2	Treatment of advanced gastroenteropancreatic neuroendocrine neoplasia, are we on the way to personalised medicine? Gut ·Anja Rinke, Christoph J. Auernhammer, Lisa Bodei, Mark Kidd, Sebastian Krug, Rita T. Lawlor, Ilaria Marinoni, Aurel Perren, Aldo Scarpa, Halfdan Sørbye, Marianne Pavel, Matthias M. Weber, Irvin M. Modlin, Thomas M. Gress	2021	24
3	Measurement of circulating transcript levels (NETest) to detect disease recurrence and improve follow‐up after curative surgical resection of well‐differentiated pancreatic neuroendocrine tumors Journal of Surgical Oncology ·W. Barraclough, Anneke P. J. Jilesen, Els J.�M. Nieveen van Dijkum, Heinz‐Josef Klümpen, Casper H.J. van Eijck, Ignat Drozdov, Anna Malczewska, Mark Kidd, Irvin M. Modlin	2018	31
4	Molecular strategies in the management of bronchopulmonary and thymic neuroendocrine neoplasms Journal of Thoracic Disease ·Irvin M. Modlin, Mark Kidd, Pier Luigi Filosso, Beatriz Santamarina Campos, Anna Lewczuk, Jarosław B. Ćwikła, Lisa Bodei, Martin Bayer, Natalia Andrea Pinilla Rivera, Margot Tesselaar, Ignat Drozdov	2017	10
5	Recommendations for management of patients with neuroendocrine liver metastases The Lancet Oncology ·Andrea Frilling, Irvin M. Modlin, Mark Kidd, Christopher Russell, Stefan Breitenstein, Riad Salem, Dik J. Kwekkeboom, Wan-Yee Lau, Catherine Klersy, Valérie Vilgrain, Brian R Davidson, Mark Siegler, Martyn Caplin, Enrico Solcia, Richard L. Schilsky Hit paper breakdown →	2014	349
6	The clinical implications and biologic relevance of neurofilament expression in gastroenteropancreatic neuroendocrine neoplasms Cancer ·Simon Schimmack, Ben Lawrence, Bernhard Svejda, Daniele Alaimo, Hubertus Schmitz‐Winnenthal, Lars Fischer, Markus W. Büchler, Mark Kidd, Irvin M. Modlin	2011	16
7	Adenosine A2 receptor signalling mediates chromogranin A secretion from neuroendocrine Tumours Andy Ying, Manuel Vázquez‐Carrera, Bharat Jasani, Jennifer B. Stott, James Neal, Borzo Gharibi, Mark Kidd, Irvin M. Modlin, Roswitha Pfragner, Aled Rees, J. Ham	2009	2
8	Nikolai Konstantinovich Kulchitsky (1856–1925) Journal of Medical Biography ·Ignat Drozdov, Irvin M. Modlin, Mark Kidd, Petre Deutsch	2009	1
9	Neuroendocrine tumor epidemiology Cancer ·Øyvind Hauso, Björn Gustafsson, Mark Kidd, Helge L. Waldum, Ignat Drozdov, Anthony Chan, Irvin M. Modlin	2008	392
10	Siegfried Oberndorfer and the Evolution of Carcinoid Disease Archives of Surgery ·Irvin M. Modlin	2007	24
11	Surgery for Obesity: Panacea or Pandora’s Box? Digestive Surgery ·Rahul Pannala, Mark Kidd, Irvin M. Modlin	2006	7
12	Acid Related Diseases: Biology and Treatment Gut ·George Sachs, Irvin M. Modlin, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	2005	25
13	GERD 2003 – A Consensus on the Way Ahead Digestion ·Steven F. Moss, David Armstrong, R. Arnold, Péter Ferenci, Kwong Ming Fock, Gerald Holtmann, Denis M. McCarthy, Joaquim P. Moraes-Filho, E. Mutschler, Raymond J. Playford, Stuart J. Spechler, Vincenzo Stanghellini, Irvin M. Modlin	2003	37
14	Consensus Statement for Management of Gastroesophageal Reflux Disease Journal of Clinical Gastroenterology ·Steven F. Moss, R. Arnold, G. N. J. Tytgat, Stuart J. Spechler, G. Delle Fave, Danny Rosin, Mary Grace Plesing, Irvin M. Modlin	1998	23
15	A Century of Helicobacter pylori Digestion ·Mark Kidd, Irvin M. Modlin	1998	60
16	The Mastomys Gastric Carcinoid: Aspects of Enterochromaff in-Like Cell Function Digestion ·Irvin M. Modlin, Azwar Saleh, Laura H. Tang, John P. Geibel, J Modzelewski, Umer Darr	1994	23
17	Mediation of the trophic effects of short-chain fatty acids on the rat jejunum and colon Gastroenterology ·Wendy L. Frankel, 德海吴, J. Maisonnier, David M. Klurfeld, Mariyem Abouri, Takashi Sakata, Irvin M. Modlin, John L. Rombeau	1994	183
18	Deoxycholate is an important releaser of peptide YY and enteroglucagon from the human colon. Gut ·Thomas E. Adrian, Garth H. Ballantyne, Walter E. Longo, Anton J. Bilchik, R. Franceschini, Marc D. Basson, Evaritus Janggu, Irvin M. Modlin	1993	93
19	Bile salt inhibition of motility in the isolated perfused rabbit terminal ileum. Gut ·David N. Armstrong, J Li, Irvin M. Modlin, Garth H. Ballantyne	1993	36
20	Cholinergic component in the human pancreatic secretory response to intraintestinal oleate. Gut ·Jorge E. Valenzuela, C B Lamers, Irvin M. Modlin, John H. Walsh	1983	27

About Irvin M. Modlin

Irvin M. Modlin is a scholar working on Gastroenterology, Neurology, Epidemiology, Oncology and Cellular and Molecular Neuroscience, having authored 393 papers that have together received 20.6k indexed citations. Recurring topics across this work include Neuroendocrine Tumor Research Advances (193 papers), Lung Cancer Research Studies (110 papers), Neuroblastoma Research and Treatments (94 papers), Neuropeptides and Animal Physiology (55 papers), Helicobacter pylori-related gastroenterology studies (47 papers), Pancreatic and Hepatic Oncology Research (40 papers), Gastroesophageal reflux and treatments (26 papers) and Receptor Mechanisms and Signaling (17 papers). The work is most often cited by research in Neurology (7.8k citations), Gastroenterology (2.4k citations), Oncology (11.6k citations), Epidemiology (12.7k citations) and Surgery (4.8k citations). Irvin M. Modlin has collaborated with scholars based in United States, Germany and United Kingdom. Frequent co-authors include Mark Kidd, Kevin D. Lye, András Sándor, Björn Gustafsson, Ignat Drozdov, Lisa Bodei, Anthony Chan, Michael D. Shapiro, Garth H. Ballantyne and Steven F. Moss. Their work appears in journals such as Journal of Clinical Gastroenterology, Journal of Surgical Research, Gastroenterology, American Journal of Physiology-Gastrointestinal and Liver Physiology and Neuroendocrinology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact